Compare MGA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGA | PODD |
|---|---|---|
| Founded | 1957 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2B | 17.0B |
| IPO Year | 1995 | 2007 |
| Metric | MGA | PODD |
|---|---|---|
| Price | $60.13 | $239.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 20 |
| Target Price | $59.40 | ★ $358.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.0M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | ★ 3.15% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.48 |
| Revenue | N/A | ★ $2,708,100,000.00 |
| Revenue This Year | $4.34 | $24.33 |
| Revenue Next Year | $2.35 | $19.33 |
| P/E Ratio | ★ $22.81 | $70.10 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $30.39 | $230.08 |
| 52 Week High | $69.94 | $354.88 |
| Indicator | MGA | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 38.13 |
| Support Level | $43.62 | $238.68 |
| Resistance Level | $69.94 | $299.75 |
| Average True Range (ATR) | 2.04 | 8.49 |
| MACD | -0.61 | 0.74 |
| Stochastic Oscillator | 1.21 | 8.45 |
Magna International prides itself on an entrepreneurial culture and a corporate constitution that outlines the distribution of profits to various stakeholders. This automotive supplier's product groups include exteriors, interiors, seating, roof systems, body and chassis, powertrain, vision and electronic systems, closure systems, electric vehicle systems, tooling and engineering, and contract vehicle assembly. In 2024, 48% of Magna's USD 42.8 billion of revenue came from North America, while Europe accounted for approximately 37% and Asia the remainder. The firm's top six customers constituted 72.9% of revenue, with the top three being GM, Mercedes, and Ford. GM was the largest contributor at 15.4%. Magna was founded in 1957, has over 170,000 employees, and is based in Aurora, Ontario.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.